![4d Pharma Plc](https://directorstalk.net/wp-content/uploads/2016/09/4d-pharma-plc.png)
10 common signs of irritable bowel syndrome
Irritable bowel syndrome (IBS) is a common disorder of the large intestine resulting in cramping, bloating, abdominal pain, mucus in the colon, gas, and diarrhea or constipation or even both.
Irritable bowel syndrome (IBS) is a common disorder of the large intestine resulting in cramping, bloating, abdominal pain, mucus in the colon, gas, and diarrhea or constipation or even both.
The bacteria in your gut are incredibly important for your health and weight, writes consultant gastroenterologist Dr Deirdre O’Donovan. If you want better immunity, efficient digestion, improved clarity and balance,
Digestive problems including IBS are common, but a low FODMAP diet may be helpful for some sufferers. Research suggests there is a strong connection between symptoms such as gas, bloating,
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, t0day announced the randomisation of the first patient in a Phase II clinical trial of Blautix
A bloated stomach is most often caused by excess or trapped wind, which can happen when consuming foods and drinks which are hard to digest. However, if you are finding
IBS is often a life long problem but symptoms can come and go over time. Symptoms include stomach cramps, bloating, diarrhoea and constipation, and while theses conditions can be eased
Unfortunately doctors still don’t know what causes irritable bowel syndrome (IBS) but they believe that a combination of problems can lead to the condition. They do , however, know that
It was the mid-1990s. The incident involved a self-service counter and one bowl that contained hidden nuts. Adam was 10 years old. I was older, but still at school. I
The proximity of the anus to the genitals, Freud tells us, is the source of much if not all human neurosis. It’s fashionable to distance oneself from Freud these days,
A LifeSci Capital report presented a handful of key points about 4D Pharma. Analyst Patrick Dolezal reported that LifeSci Capital initiated coverage on 4D Pharma Plc (LON:DDDD), a United Kingdom-based